Tag: Outperformed
Roivant immune drug significantly outperformed placebo in treating rare skin disease
Roivant and its spinout Priovant made a groundbreaking announcement on Friday regarding their immune-modifying drug brepocitinib. The drug…
3 Stocks That Outperformed Palantir in 2025. Can They Repeat in 2026?
In 2025, Palantir Technologies (PLTR) saw a remarkable surge of 123% as the demand for its AI-driven data…